Telix Pharmaceuticals Limited today announces that a first patient has been dosed in the Phase 1 ZOLAR[1] trial of TLX300-CDx ...

在其他近期新闻中，泰利克斯制药有限公司宣布美国食品药品监督管理局批准了其新型前列腺癌成像剂Gozellix®。这种成像剂专为PET扫描设计，用于检测疑似转移性前列腺癌男性患者的PSMA阳性病变。该批准预计将改善美国尖端PSMA-PET成像的可及性，泰利克斯预计Gozellix®将获得全额报销。此外，泰利克斯制药已完成对ImaginAb生物制剂技术平台和治疗候选药物的收购，前期成本为4500万美元。

Jakub Porzycki / NurPhoto via Getty Images Telix Pharmaceuticals reported that the U.S. Food and Drug Administration approved its agent indicated for prostate cancer screenings. Gozellix is ...

Cade Cunningham is powering the Pistons with career-best numbers and leading them into the playoff race. Juan Pablo Aravena, RotoWire.com Cade Cunningham is having a career-best season for Detroit ...

Learn More Telix Pharmaceuticals Ltd (ASX: TLX) shares have slipped by around 11% from their former highs of $31 apiece since February. This isn't a Telix-only issue. The S&P/ASX 200 Index (ASX ...

Detroit basketball fans have a new chant. In addition to the "DE-TROIT BASKETBALL" thing—more of a shout, really, but you take my meaning—they now chant "M-V-P" for young Cade Cunningham, who in his ...

Cade Cunningham remains the favorite to win the 2025 NBA Most Improved Player Award. Cunningham has dominated the power rankings over the past few months after cementing himself as an All-Star for ...

Copyright 2025 The Associated Press. All Rights Reserved. Detroit Pistons guard Cade Cunningham (2) celebrates after scoring the winning basket during the second half ...

The Detroit Pistons sent Miami Heat fans home in frustration on Wednesday night after former Oklahoma State Cowboys star and 2025 NBA All-Star selection Cade Cunningham drilled a three-pointer to ...